ChengDu ShengNuo Biotec Co.,Ltd.

¥15.01As of Sun 8 Nov 2026, 12:00 UTC
SSE:688117Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (2.29%)
Div yield 1.67%
ROE 18.21%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.70
PE TTM 16.44
TSR TTM (48.71%)
Mkt cap ¥3.307B
ROIC 14.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥18
21.48%
(19.74%)
Hold 0|0|11|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.15
0.16
0.16
18.29%
4.89%
13.42%
2.58%
Revenue¥M
157.3
160.9
161.5
162.2
(1.09%)
1.16%
2.88%
3.63%
Peers (US$495.8M)
Cap (US$)
PE
495.8M
—
499.0M
3.720x
Capital
TTM
5Y
10Y
Leveragex
0.398
0.149
0.125
EBIT/Intx
10.50
0.331
0.301
Own earn%
59.23
(9.97)
(11.07)
Sh yield%
40.46
5.29
7.69
Owners
Insiders/Inst%
1.09
33.07
Short interest%
3.00
SBC / revenue%
1.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
15–19
$1 testx
—
Incr. ROIC%
3